164 related articles for article (PubMed ID: 21153531)
1. The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes.
Alssema M; Vistisen D; Heymans MW; Nijpels G; Glümer C; Zimmet PZ; Shaw JE; Eliasson M; Stehouwer CD; Tabák AG; Colagiuri S; Borch-Johnsen K; Dekker JM;
Diabetologia; 2011 May; 54(5):1004-12. PubMed ID: 21153531
[TBL] [Abstract][Full Text] [Related]
2. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome.
Saaristo T; Peltonen M; Lindström J; Saarikoski L; Sundvall J; Eriksson JG; Tuomilehto J
Diab Vasc Dis Res; 2005 May; 2(2):67-72. PubMed ID: 16305061
[TBL] [Abstract][Full Text] [Related]
3. Development of a screening tool using electronic health records for undiagnosed Type 2 diabetes mellitus and impaired fasting glucose detection in the Slovenian population.
Štiglic G; Kocbek P; Cilar L; Fijačko N; Stožer A; Zaletel J; Sheikh A; Povalej Bržan P
Diabet Med; 2018 May; 35(5):640-649. PubMed ID: 29460977
[TBL] [Abstract][Full Text] [Related]
4. Two risk score models for predicting incident Type 2 diabetes in Japan.
Doi Y; Ninomiya T; Hata J; Hirakawa Y; Mukai N; Iwase M; Kiyohara Y
Diabet Med; 2012 Jan; 29(1):107-14. PubMed ID: 21718358
[TBL] [Abstract][Full Text] [Related]
5. The product of fasting plasma glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged Koreans.
Lee JW; Lim NK; Park HY
BMC Endocr Disord; 2018 May; 18(1):33. PubMed ID: 29843706
[TBL] [Abstract][Full Text] [Related]
6. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study.
Franciosi M; De Berardis G; Rossi MC; Sacco M; Belfiglio M; Pellegrini F; Tognoni G; Valentini M; Nicolucci A
Diabetes Care; 2005 May; 28(5):1187-94. PubMed ID: 15855587
[TBL] [Abstract][Full Text] [Related]
7. Update of the German Diabetes Risk Score and external validation in the German MONICA/KORA study.
Mühlenbruch K; Ludwig T; Jeppesen C; Joost HG; Rathmann W; Meisinger C; Peters A; Boeing H; Thorand B; Schulze MB
Diabetes Res Clin Pract; 2014 Jun; 104(3):459-66. PubMed ID: 24742930
[TBL] [Abstract][Full Text] [Related]
8. The validity of the Finnish Diabetes Risk Score for the prediction of the incidence of coronary heart disease and stroke, and total mortality.
Silventoinen K; Pankow J; Lindström J; Jousilahti P; Hu G; Tuomilehto J
Eur J Cardiovasc Prev Rehabil; 2005 Oct; 12(5):451-8. PubMed ID: 16210931
[TBL] [Abstract][Full Text] [Related]
9. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?
Stern MP; Williams K; Haffner SM
Ann Intern Med; 2002 Apr; 136(8):575-81. PubMed ID: 11955025
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus-The STOP-NIDDM risk-score.
Tuomilehto J; Lindström J; Hellmich M; Lehmacher W; Westermeier T; Evers T; Brückner A; Peltonen M; Qiao Q; Chiasson JL
Diabetes Res Clin Pract; 2010 Feb; 87(2):267-74. PubMed ID: 20022651
[TBL] [Abstract][Full Text] [Related]
11. A Colombian diabetes risk score for detecting undiagnosed diabetes and impaired glucose regulation.
Barengo NC; Tamayo DC; Tono T; Tuomilehto J
Prim Care Diabetes; 2017 Feb; 11(1):86-93. PubMed ID: 27727004
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Finnish Type 2 Diabetes Risk Score (FINDRISC) with the OGTT in Health Care Practices in Europe.
Gabriel R; Acosta T; Florez K; Anillo L; Navarro E; Boukichou N; Acosta-Reyes J; Barengo NC; Lindström J; Tuomilehto JO; Aschner P
Diabetes Res Clin Pract; 2021 Aug; 178():108976. PubMed ID: 34302911
[TBL] [Abstract][Full Text] [Related]
13. Finnish Diabetes Risk Score to predict type 2 diabetes in the Isfahan diabetes prevention study.
Janghorbani M; Adineh H; Amini M
Diabetes Res Clin Pract; 2013 Dec; 102(3):202-9. PubMed ID: 24262944
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Finnish Diabetes Risk Score Model With the Metabolic Syndrome in a Shanghai Population.
Jin S; Chen Q; Han X; Liu Y; Cai M; Yao Z; Lu H
Front Endocrinol (Lausanne); 2022; 13():725314. PubMed ID: 35273562
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study.
Hellgren MI; Petzold M; Björkelund C; Wedel H; Jansson PA; Lindblad U
Diabet Med; 2012 Dec; 29(12):1501-5. PubMed ID: 22443428
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population.
Saaristo TE; Barengo NC; Korpi-Hyövälti E; Oksa H; Puolijoki H; Saltevo JT; Vanhala M; Sundvall J; Saarikoski L; Peltonen M; Tuomilehto J
BMC Public Health; 2008 Dec; 8():423. PubMed ID: 19113993
[TBL] [Abstract][Full Text] [Related]
17. Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.
Salinero-Fort MA; Burgos-Lunar C; Lahoz C; Mostaza JM; Abánades-Herranz JC; Laguna-Cuesta F; Estirado-de Cabo E; García-Iglesias F; González-Alegre T; Fernández-Puntero B; Montesano-Sánchez L; Vicent-López D; Cornejo-Del Río V; Fernández-García PJ; Sánchez-Arroyo V; Sabín-Rodríguez C; López-López S; Patrón-Barandio P; Gómez-Campelo P;
PLoS One; 2016; 11(7):e0158489. PubMed ID: 27441722
[TBL] [Abstract][Full Text] [Related]
18. A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population.
Bergmann A; Li J; Wang L; Schulze J; Bornstein SR; Schwarz PE
Horm Metab Res; 2007 Sep; 39(9):677-82. PubMed ID: 17846976
[TBL] [Abstract][Full Text] [Related]
19. Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D).
Saaristo T; Moilanen L; Jokelainen J; Korpi-Hyövälti E; Vanhala M; Saltevo J; Niskanen L; Peltonen M; Oksa H; Cederberg H; Tuomilehto J; Uusitupa M; Keinänen-Kiukaanniemi S
Prim Care Diabetes; 2010 Dec; 4(4):231-9. PubMed ID: 21134669
[TBL] [Abstract][Full Text] [Related]
20. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study.
Talmud PJ; Hingorani AD; Cooper JA; Marmot MG; Brunner EJ; Kumari M; Kivimäki M; Humphries SE
BMJ; 2010 Jan; 340():b4838. PubMed ID: 20075150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
